PRA Health Sciences (PRAH) Tops Q2 EPS by 3c, Revenues Beat: Offers FY20 EPS Outlook Above Consensus, FY20 Revenue Mid-Point View Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to PRA Health Sciences (PRAH) Tops Q2 EPS by 3c, Revenues Beat: Offers FY20 EPS Outlook Above Consensus, FY20 Revenue Mid-Point View Above Consensus

PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities

August 7, 2020 2:01 PM EDT

Mizuho Securities analyst Ann Hynes raised the price target on PRA Health Sciences (NASDAQ: PRAH) to $108.00 (from $92.00) while maintaining a Neutral rating.

... More